`

TargED Biopharmaceuticals

Pharmaceutical Manufacturing

Specialities :
Biologicals
Thrombolysis
And microvascular thrombosis
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About TargED Biopharmaceuticals

What does Targed biopharmaceuticals do?+

TargED started in September 2018 and is currently developing one biopharmaceutical product: MICROLYSE. MICROLYSE enzymatically breaks down blood clots in small blood vessels (i.e. the microvasculature), for which to date, no specific treatment exists. TargED pursues to receive market authorization for an orphan disease named Thrombotic Thrombocytopenic Purpura (TTP) that is characterized by life threatening attacks of microvascular thrombosis. However, MICROLYSE has the capacity to target all forms of microvascular thrombosis and could also be applied in early-stage macrovascular thrombosis as seen in heart attacks and stroke

What are Targed biopharmaceuticals's specialties? +

Biologicals,thrombolysis,and microvascular thrombosis

What is Targed biopharmaceuticals's industry? +

Targed biopharmaceuticals operates in the Pharmaceutical manufacturing industry.

What is Targed biopharmaceuticals's revenue? +

Targed biopharmaceuticals's revenue is 11m - 100m

What is Targed biopharmaceuticals's company size? +

Targed biopharmaceuticals has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.